Portal:CPTAC/Hallmarks

From WikiPathways

Jump to: navigation, search
Sustaining proliferative signaling

FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma (Homo sapiens)

FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma
FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma
Evading growth suppressors

G1 to S cell cycle control (Homo sapiens)

G1 to S cell cycle control
G1 to S cell cycle control
Activating invasion and metastasis

Integrin-mediated cell adhesion (Homo sapiens)

Integrin-mediated cell adhesion
Integrin-mediated cell adhesion
Enabling replicative immortality

ncRNAs involved in STAT3 signaling in hepatocellular carcinoma (Homo sapiens)

ncRNAs involved in STAT3 signaling in hepatocellular carcinoma
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma
Inducing angiogenesis

Angiogenesis (Homo sapiens)

Angiogenesis
Angiogenesis
Resisting cell death

Target of rapamycin signaling (Homo sapiens)

Target of rapamycin signaling
Target of rapamycin signaling
Deregulating cellular energetics

TCA cycle nutrient use and invasiveness of ovarian cancer (Homo sapiens)

TCA cycle nutrient use and invasiveness of ovarian cancer
TCA cycle nutrient use and invasiveness of ovarian cancer
Genome instability and mutation

Methylation pathways (Homo sapiens)

Methylation pathways
Methylation pathways
Tumor promoting inflammation

Chemokine signaling pathway (Homo sapiens)

Chemokine signaling pathway
Chemokine signaling pathway
Avoiding immune destruction

Type II interferon signaling (Homo sapiens)

Type II interferon signaling
Type II interferon signaling
Therapeutics

MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement (Homo sapiens)

MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement
MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement